| 2024/08/16 17:31:02 | |
|---|---|
| Price | |
| 411.00 CHF | |
| Difference | 0.37% (1.50) |
General attributes
| ISIN | CH0019396990 |
| Symbol | YPSN |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 5,849 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 410.50 CHF (57) |
| Ask (Ask size) | 411.00 CHF (118) |
| Open | 410.00 CHF |
| High | 411.50 CHF |
| Low | 408.50 CHF |
| Close (prev. day) | 409.50 CHF |
| VWAP | 410.528668 CHF |
| Volume (pcs) | 3,558 |
| Trading volume | 1,460,661.00 |
| Number of trades | 237 |
| Last size | 1 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: YPSOMED HOLDING AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/08/16 17:31:02 | |
|---|---|
| Price | |
| 411.00 CHF | |
| Difference | 0.37% (1.50) |
General attributes
| ISIN | CH0019396990 |
| Symbol | YPSN |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 5,849 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 410.50 CHF (57) |
| Ask (Ask size) | 411.00 CHF (118) |
| Open | 410.00 CHF |
| High | 411.50 CHF |
| Low | 408.50 CHF |
| Close (prev. day) | 409.50 CHF |
| VWAP | 410.528668 CHF |
| Volume (pcs) | 3,558 |
| Trading volume | 1,460,661.00 |
| Number of trades | 237 |
| Last size | 1 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +19.48% | +53.93% | +182.37% |
| Perf (abs.) | +67.00 | +144.00 | +265.45 |
| Beta | 0.50 | 0.70 | 0.88 |
| Volatility | 34.08 | 31.13 | 31.33 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 405.30 CHF (4,600) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 405.43 CHF (10,035) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 382.86 CHF (13,115) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 329.16 CHF (12,631) |
| YTD High | date | 432.00 CHF (2024/07/15) |
| YTD Low | date | 287.50 CHF (2024/01/17) |
| 52 Weeks High | date | 432.00 CHF (2024/07/15) |
| 52 Weeks Low | date | 243.50 CHF (2023/10/06) |
All listings for YPSOMED HOLDING AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| SIX Swiss Exchange | 2024/08/16 | 17:31 | 411.00 CHF | 1.46 | 237 |
| London Stock Exchange | 2024/05/21 | 16:12 | 339.50 CHF | 0.16 | 1 |
| Frankfurt | 2019/06/28 | 15:43 | 120.60 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/08/02 | 15:48 | 452.47 USD | 0.00 | 1 |
| Berlin | 2019/06/28 | 15:59 | 120.80 EUR | 0.00 | 5 |
Company Logo
Contact Details
| YPSOMED HOLDING AG |
| - - |
| Brunnmattstrasse 6 - 3401 Burgdorf |
| Telefon: +41-34-424-41-11 |
| Fax: + |
| E-mail: info@ypsomed.com |
PDF Downloads
| Company report: YPSOMED HOLDING AG | |
Company Profile
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. It operates through the following segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others. The Ypsomed Diabetes Care segment is involved in the products that are sold directly to hospitals, doctors, pharmacies, and patients via Ypsomed subsidiaries and distributors. The Ypsomed Delivery Systems segment focuses on the pharmaceutical and biotech customers with injection systems and related services. The Others segment consists of Ypsotec and properties not used for operational purposes. The company was founded by Wilhelm Michel on December 29, 2003, and is headquartered in Burgdorf, Switzerland. |
Members of Management Board
| Simon Michel | Chairman of Managing Board |
| Frank Mengis | Member of Executive Committee |
| Michael Zaugg | Member of Executive Committee |
| Niklaus Ramseier | Member of Executive Committee |
| Sébastien Delarive | Member of Executive Committee |
| Ulrike Bauer | Member of Executive Committee |
Board of directors
| Martin C. Münchbach | Member of the administrative board |
| Betül Susamis Unaran | Member of the administrative board |
| Paul R. Fonteyne | Member of the administrative board |
| Gilbert Achermann | Chairman of the administrative boar |